{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EMA Herbal Substance|Uses|Pain and Inflammation|Skin Disorders and Minor Wounds" in comments (approximate match)
Showing 1 - 2 of 2 results
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT04656730: Phase 4 Interventional Completed Irritable Bowel Syndrome
(2020)
Source URL:
First approved in 2008
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE